Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Medical Equipment Manufacturing
Celleo Biotech runs a Medical Equipment Manufacturing operation from Melbourne, Victoria. Privately held, at celleo.com. It holds one address on record, all in Australia. It employs 23 people, on the record. One Australian registration (ABN) is a confirmed match. Its latest round on record is Non equity assistance, with no amount recorded. The record links ten similar brands, most of them in Biotechnology Research.
ABN30658299542
| CELLEO BIOTECH PTY LTD | ABN 30658299542 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Celleo originated at the intersection of great biology and great engineering. Sparks fly at the intersection.
Our mission is to enable Cell & Gene Therapies to deliver population-level health outcomes, realizing the extraordinary potential of humanity’s most powerful therapeutic modality – our cells, augmented.
We contribute intelligent production systems for the manufacture of Cell & Gene Therapies.
Our 3 co-founders each bring nearly 20 years of deep industry experience in the development and production of Cell & Gene Therapies. Celleo develops GMP production systems in collaboration with leading commercial biotherapeutics players, developers of novel therapeutics at pre-clinical to clinical stage, CDMOs, and major university medical centers. Our production systems seek to accommodate, not dictate, the diversity of processes, modalities and business models characteristic of our vibrant industry.
Steve Jobs predicted “…the biggest innovations of the 21st century will be at the intersection of biology and technology.” Today’s Cell & Gene Therapy industry is approaching a tipping point – from a limited set of therapeutics changing the lives of a fortunate few, to a broadly available toolkit for physicians providing a new standard of personalized care. We’re here to hasten that transition.
Millions of patients in need deserve it.
Thousands of Cell Therapy professionals deserve it too.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
| Rounds | 1 |
|---|---|
| Axis | 2022 to 2026 |
| Non equity assistance · 14 Sep 2024 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Victoria entity on the ABR: CELLEO BIOTECH PTY LTD (ABN 30 658 299 542), high confidence.
23 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Australia only. Primary: 655 Elizabeth St, Melbourne, Victoria 3000.
One round. Latest 14 September 2024: non equity assistance, investor University Lab Partners, no amount recorded.
8 profiles list Celleo Biotech as a peer — 84th percentile in Medical Equipment Manufacturing. It lists ten peers of its own. CCRM Australia and Immunosis list it back.